Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
04 May 2018 Photo Facebook
Kovsies aim top 6 in Varsity hockey Cheslyn Neethling
Cheslyn Neethling will lead the Kovsie men’s hockey team in the Varsity Hockey tournament.
The Kovsie men’s hockey team hope to draw inspiration from their victory over the North-West University recently when they face their old rivals in the opening round of the Varsity Hockey tournament.

The tournament for men, which is contested biannually, starts on Friday 4 May 2018.

The Kovsies played the Pukke in two matches in Potchefstroom at the end of March with both sides on the winning side once each.

According to the coach Braam van Wyk it will give them a lot of confidence when they come up against the Pukke on Friday afternoon (4 May) in Johannesburg.

“We hope to finish in the top six, anything better than that will be a bonus,” said Van Wyk, in his third year as coach of the team.

They reached the semi-final in 2014 and ended seventh in 2016.

It is a short tournament of just two-and-a-half weeks with the final on 21 May 2018. 

On Saturday 5 May they tackle the University of Johannesburg who won the inaugural men’s tournament in 2014 and defended it in 2016.

The Madibaz lay in wait on Sunday 6 May and on Monday 7 Mayat the University of Cape Town. 

Van Wyk, who played for the Kovsies between 2006 and 2009, said he is in favour of the power play. Each side has one in a match. For three minutes the team will be without two players, with goals worth two points. In addition, all field goals are worth two points. If a match is drawn it will go straight to a shootout.

The Kovsies are led by Cheslyn Neethling. Two players, Egon van der Merwe and Jan Willem Ras, will feature in their third Varsity tournament.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 
Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept